Future Elderly Model

Understanding the relationship between health status and lifetime spending

Prescription drugs and Medicare Part D

Welfare Analysis of Medicare Part D (Neeraj Sood)

Protecting the vulnerable elderly

Study on Extending Exclusive Access to Clinical Trial Data First to Estimate Impacts

Goldman et al. publish new study in January Health Affairs demonstrating that extending the data exclusivity term for conventional drugs would positively impact innovation, longevity and social welfare.
Study Finds Higher STD Rates Among Users of Erectile Dysfunction Drugs

Anupam Jena, M.D. and Dana Goldman, Ph.D. analyzed 1.4 million insurance records of men over 40 and found that those who used ED drugs were more likely to have STDs than non-users. Results suggest counseling on safer sex practices important for older men.
How To Live 100 Years

For TIME, Dana Goldman et al. use their innovative Future Elderly Model to simulate an hypothetical long-life pill, getting dramatic economic and health spending results.
USC & RAND Economists Win Garfield Prize
USC & RAND Economists Win Garfield Prize Darius Lakdawalla and his co-authors received the 2009 Eugene Garfield Economic Impact on Medical and Health Research award for their study on how methods to lower drug prices affect medical innovation and, ultimately,...